{{Distinguish|Episterol}}
{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = (8R,9S,13S,14S,16S,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol
| image = Epiestriol.svg
| width =

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 547-81-9
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 68929
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 62155
| UNII = 8XZ32LI44K
| ChEMBL = 1908074

<!--Chemical data-->
| C=18 | H=24 | O=3
| molecular_weight = 288.38136 g/mol
| smiles = CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O
| StdInChI_Ref = 
| StdInChI = 1S/C18H24O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-17,19-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16+,17+,18+/m1/s1
| StdInChIKey_Ref = 
| StdInChIKey = PROQIPRRNZUXQM-ZMSHIADSSA-N
| synonyms = 
}}

'''Epiestriol''' ([[International Nonproprietary Name|INN]]) (brand names '''Actriol''', '''Arcagynil''', '''Klimadoral'''), or '''epioestriol''' ([[British Approved Name|BAN]]), also known as '''16β-epiestriol''' or simply '''16-epiestriol''' as well as '''16β-hydroxy-17β-estradiol''', is a minor and weak [[endogenous]] [[estrogen]], and the 16β-[[epimer]] of [[estriol]] (which is 16α-hydroxy-17β-estradiol).<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA899|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=899–}}</ref><ref name="Labhart2012">{{cite book|author=A. Labhart|title=Clinical Endocrinology: Theory and Practice|url=https://books.google.com/books?id=DAgJCAAAQBAJ&pg=PA522|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-3-642-96158-8|pages=522–}}</ref> Epiestriol is (or has previously been) used clinically in the treatment of [[acne]].<ref name="Elks2014" /> In addition to its estrogenic actions, epiestriol has been found to possess significant [[anti-inflammatory]] properties without [[glycogenesis|glycogenic]] activity or [[immunosuppressive]] effects, an interesting finding that is in contrast to conventional anti-inflammatory steroids like [[hydrocortisone]] (a [[glucocorticoid]]).<ref name="pmid9120824">{{cite journal | title=16-epiestriol: an anti-inflammatory steroid without glycogenic activity | journal=J Pharm Sci | vauthors=Latman NS, Kishore V, Bruot BC | year=1994 | volume=83 | issue=6 | pages=874–7 | doi=10.1002/jps.2600830623 | pmid=9120824}}</ref><ref name="pmid9858313">{{cite journal | vauthors = Miller E, Bates R, Bjorndahl J, Allen D, Burgio D, Bouma C, Stoll J, Latman N | title = 16-Epiestriol, a novel anti-inflammatory nonglycogenic steroid, does not inhibit IFN-gamma production by murine splenocytes | journal = J. Interferon Cytokine Res. | volume = 18 | issue = 11 | pages = 921–5 | year = 1998 | pmid = 9858313 | doi = 10.1089/jir.1998.18.921 | url = }}</ref>

==See also==
* [[17α-Epiestriol]]
* [[16β,17α-Epiestriol]]
* [[Epimestrol]]
* [[Mytatrienediol]]

==References==
{{reflist}}

{{Steroid hormones}}
{{Acne agents}}
{{Estrogens}}
{{Estrogenics}}

[[Category:Anti-acne preparations]]
[[Category:Anti-inflammatory agents]]
[[Category:Estranes]]
[[Category:Estrogens]]
[[Category:Hormones of the hypothalamus-pituitary-gonad axis]]
[[Category:Sex hormones]]


{{genito-urinary-drug-stub}}
{{steroid-stub}}